HCA Maintained by TD Cowen -- Price Target Raised to $460

gurufocus.com · 2026-10-12

HCA Healthcare Analyst Rating Update On October 12, 2026, TD Cowen analyst Ryan Langston maintained a 'Buy' rating on HCA Healthcare (HCA) and raised the pri

TickrTrends take: TD Cowen's maintained rating on HCA alongside a price target increase to $460 suggests analyst confidence in the company's fundamentals, which aligns with TickrTrends' fairly valued assessment of the healthcare operator. For valuation-focused investors, this development indicates that upside potential may exist if HCA can execute on the factors supporting Cowen's elevated target, while the fairly valued status suggests current pricing already reflects much of the company's known strengths. Investors should monitor whether HCA's operational performance and financial metrics can justify a move toward the $460 target or whether the fairly valued designation will persist.

Read the full story at gurufocus.com →